Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Differential effects of intra-ventral tegmental area ghrelin and glucagon-like peptide-1 on the stimulatory action of d-amphetamine and cocaine-induced ethanol intake in male Sprague Dawley rats
Hydroxocobalamin and pregnancy
L carnitine in hemodialysis research subjects [PMID: 22360675] Laboratory literature summary: L carnitine in hemodialysis research subjects
Structure's GLP-1 Pill Could Be Big, But Trial Results Will Confirm Structure Therapeutics Today GPCR Structure Therapeutics $48.36 +0.32 (+0.67%) As of 04:00 PM Eastern 52-Week Range $15.80 $94.90 Price Target $110.55 Shares of Structure Therapeutics NASDAQ: GPCR have far outperformed both of the companies above in the last year, rising by over 150% during that time as investors have grown enthusiastic about aleniglipron, the firm's GLP-1 agonist candidate
US$ 24.19
US$ 23.92
US$ 20.45
US$ 22.72
